학술논문

A Phase II Open Label Study of Everolimus in Combination With Endocrine Therapy in Resistant Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer
Document Type
Article
Source
In: Clinical Breast Cancer. (Clinical Breast Cancer, April 2020, 20(2):89-97)
Subject
Language
English
ISSN
19380666
15268209